Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FZ9Q8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,573
Award facts
- Contract value 100% obligated
- $9,572.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $9,572.59 to AmerisourceBergen Drug Corp for the supply of Xeljanz XR 11 mg tablets (30-count units). This firm fixed price contract, awarded on June 4, 2025, with an ultimate completion date of June 5, 2025, represents a non-competitive procurement without set-aside provisions. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle that runs through December 2026 and enables the company to supply a broad range of pharmaceutical products and medical supplies globally to support military healthcare programs.
Xeljanz XR is a branded pharmaceutical product used primarily for rheumatoid arthritis and other inflammatory conditions, reflecting the type of specialty medication that DLA procures to support Defense Health Agency beneficiaries, U.S. Coast Guard personnel, and other government healthcare systems. AmerisourceBergen's role as a prime pharmaceutical vendor demonstrates its capacity to fulfill federal medical supply requirements through open competition. The company's substantial IDC vehicle with DLA Troop Support Medical underscores its critical position within the federal medical supply chain, serving as one of multiple potential contractors in DLA's planned Pharmaceutical Prime Vendor Global Program Generation V initiative.
Quick answers
Who was awarded contract SPE2DB25FZ9Q8?
SPE2DB25FZ9Q8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 4, 2025.
How much is contract SPE2DB25FZ9Q8 worth?
The government has obligated $9,573 on SPE2DB25FZ9Q8.
Is contract SPE2DB25FZ9Q8 an order under another contract?
Yes. SPE2DB25FZ9Q8 is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB25FZ9Q8 competed?
The extent of competition for SPE2DB25FZ9Q8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award